Organisation paid for research Program year 2025 Source: CMS Open Payments

NVision Clinical Research LLC

Neither a doctor nor a teaching hospital

Research payments

$1,830,751

70 payments

Through program year 2025, NVision Clinical Research LLC is reported as receiving $1,830,751 in research payments, across 70 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $235,631 14
2024 Research $1,595,120 56

Breakdown

Who paid Research payments · program years 2024–2025
  1. Alcon Research LLC $1,132,638 36 payments
  2. Dompe Farmaceutici S.p.A. $388,977 11 payments
  3. Amgen Inc. $140,487 5 payments
  4. Genentech, Inc. $119,665 8 payments
  5. Roche TCRC, Inc. $30,984 2 payments
  6. RxSight Inc $18,000 8 payments
Studies the money was for Research payments · program years 2024–2025
  1. A Prospective Study Comparing Visual Outcomes and Patient Satisfaction Following Implantation of the Clareon PanOptix versus Tecnis Odyssey IOL in Patients Undergoing Cataract Surgery $1,132,638 36 payments
  2. A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Follow-Up to Evaluate Safety and Efficacy of a new formulation of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution at two different Concentrations in patients with Dry Eye Disease (REDUCO) $388,977 11 payments
  3. A Phase 3, Randomized, Double-masked, Placebo-controlled, Parallel-group, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous Teprotumumab in Participants With Moderate-to-Severe Active Thyroid Eye Disease $94,402 3 payments
  4. A prospective, cross-sectional study to assess the comparability of electronic ETDRS (chart presentation) against standard ETDRS charts, in a clinical trial setting, in participants with varying ranges of visual acuity $63,205 4 payments
  5. A Phase III Randomized Double Masked Placebo Controlled Multicenter Study to Evaluate the Effica $56,460 4 payments
  6. P3 SubQ active TED $46,085 2 payments
  7. Entry Into Human of Ro7497372 in Participants With Diabetic MacUlar Edema $30,984 2 payments
  8. Pmcs-002 $18,000 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record